Azitra, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Azitra, Inc. (AZTR) had Lessee, Operating Lease, Liability, to be Paid, Year One of $194.15 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-12
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $194.15K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $132.94K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $270.34K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $262.91K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $194.15K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $132.94K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $270.34K 10-K · filed 2026-02-27 |
| 2025-09-30 | $262.91K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $268.63K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $203.11K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $277.18K 10-K · filed 2025-02-24 |
| 2024-09-30 | $281.26K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $282.41K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $278.84K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $338.25K 10-K · filed 2024-03-15 |
| 2023-09-30 | $337.71K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $319.21K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |